1887

Abstract

Camelpox virus (CMLV) gene encodes a protein with sequence similarity to murine schlafen (m-slfn) proteins. , short and long members of the m-slfn family inhibited T-cell development, whereas , only short m-slfns caused arrest of fibroblast growth. CMLV 176 protein (v-slfn) is most closely related to short m-slfns; however, when expressed stably in mammalian cells, v-slfn did not inhibit cell growth. v-slfn is a predominantly cytoplasmic 57 kDa protein that is expressed throughout infection. Several other orthopoxviruses encode v-slfn proteins, but the gene is fragmented in all sequenced variola virus and vaccinia virus (VACV) strains. Consistent with this, all 16 VACV strains tested do not express a v-slfn detected by polyclonal serum raised against the CMLV protein. In the absence of a small animal model to study CMLV pathogenesis, the contribution of CMLV v-slfn to orthopoxvirus virulence was studied via its expression in an attenuated strain of VACV. Recombinant viruses expressing wild-type v-slfn or v-slfn tagged at its C terminus with a haemagglutinin (HA) epitope were less virulent than control viruses. However, a virus expressing v-slfn tagged with the HA epitope at its N terminus had similar virulence to controls, implying that the N terminus has an important function. A greater recruitment of lymphocytes into infected lung tissue was observed in the presence of wild-type v-slfn but, interestingly, these cells were less activated. Thus, v-slfn is an orthopoxvirus virulence factor that affects the host immune response to infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82748-0
2007-06-01
2021-02-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/6/1667.html?itemId=/content/journal/jgv/10.1099/vir.0.82748-0&mimeType=html&fmt=ahah

References

  1. Afonso C. L., Tulman E. R., Lu Z., Oma E., Kutish G. F., Rock D. L. 1999; The genome of Melanoplus sanguinipes entomopoxvirus. J Virol 73:533–552
    [Google Scholar]
  2. Afonso C. L., Tulman E. R., Lu Z., Zsak L., Sandybaev N. T., Kerembekova U. Z., Zaitsev V. L., Kutish G. F., Rock D. L. 2002; The genome of camelpox virus. Virology 295:1–9 [CrossRef]
    [Google Scholar]
  3. Alcami A., Smith G. L. 1992; A soluble receptor for interleukin-1 β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71:153–167 [CrossRef]
    [Google Scholar]
  4. Alcami A., Smith G. L. 1996; A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci U S A 93:11029–11034 [CrossRef]
    [Google Scholar]
  5. Bawden A. L., Glassberg K. J., Diggans J., Shaw R., Farmerie W., Moyer R. W. 2000; Complete genomic sequence of the Amsacta moorei entomopoxvirus: analysis and comparison with other poxviruses. Virology 274:120–139 [CrossRef]
    [Google Scholar]
  6. Bennink J. R., Yewdell J. W., Smith G. L., Moss B. 1986; Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes. J Virol 57:786–791
    [Google Scholar]
  7. Brady G., Boggan L., Bowie A., O'Neill L. A. 2005; Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin D1. J Biol Chem 280:30723–30734 [CrossRef]
    [Google Scholar]
  8. Buller R. M., Smith G. L., Cremer K., Notkins A. L., Moss B. 1985; Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 317:813–815 [CrossRef]
    [Google Scholar]
  9. Chakrabarti S., Brechling K., Moss B. 1985; Vaccinia virus expression vector: coexpression of β -galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol 5:3403–3409
    [Google Scholar]
  10. Clark R. H., Kenyon J. C., Bartlett N. W., Tscharke D. C., Smith G. L. 2006; Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy. J Gen Virol 87:29–38 [CrossRef]
    [Google Scholar]
  11. Davison A. J., Moss B. 1990; New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins. Nucleic Acids Res 18:4285–4286 [CrossRef]
    [Google Scholar]
  12. Eskra L., Mathison A., Splitter G. 2003; Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus . Infect Immun 71:1125–1133 [CrossRef]
    [Google Scholar]
  13. Frickey T., Lupas A. N. 2004; Phylogenetic analysis of AAA proteins. J Struct Biol 146:2–10 [CrossRef]
    [Google Scholar]
  14. Geserick P., Kaiser F., Klemm U., Kaufmann S. H., Zerrahn J. 2004; Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif. Int Immunol 16:1535–1548 [CrossRef]
    [Google Scholar]
  15. Gubser C., Smith G. L. 2002; The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J Gen Virol 83:855–872
    [Google Scholar]
  16. Law M., Hollinshead M., Lee H. J., Smith G. L. 2004; Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails. J Gen Virol 85:1279–1290 [CrossRef]
    [Google Scholar]
  17. Liu A., Qin J. C., Rankin C., Hardin S. E., Weaver R. F. 1986; Nucleotide sequence of a portion of the Autographa californica nuclear polyhedrosis virus genome containing the Eco RI site-rich region (hr5) and an open reading frame just 5′ of the p10 gene. J Gen Virol 67:2565–2570 [CrossRef]
    [Google Scholar]
  18. Lupas A. N., Martin J. 2002; AAA proteins. Curr Opin Struct Biol 12:746–753 [CrossRef]
    [Google Scholar]
  19. Moss B. 2001; Poxviridae : the viruses and their replication. In Fields Virology , 4th edn. pp 2849–2883 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
    [Google Scholar]
  20. Pires de Miranda M., Reading P. C., Tscharke D. C., Murphy B. J., Smith G. L. 2003; The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model. J Gen Virol 84:2459–2471 [CrossRef]
    [Google Scholar]
  21. Reading P. C., Smith G. L. 2003; A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol 84:1973–1983 [CrossRef]
    [Google Scholar]
  22. Schmelz M., Sodeik B., Ericsson M., Wolffe E. J., Shida H., Hiller G., Griffiths G. 1994; Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol 68:130–147
    [Google Scholar]
  23. Schwarz D. A., Katayama C. D., Hedrick S. M. 1998; Schlafen, a new family of growth regulatory genes that affect thymocyte development. Immunity 9:657–668 [CrossRef]
    [Google Scholar]
  24. Smith G. L., Levin J. Z., Palese P., Moss B. 1987; Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology 160:336–345 [CrossRef]
    [Google Scholar]
  25. Spriggs M. K., Hruby D. E., Maliszewski C. R., Pickup D. J., Sims J. E., Buller R. M., VanSlyke J. 1992; Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71:145–152 [CrossRef]
    [Google Scholar]
  26. Staib C., Kisling S., Erfle V., Sutter G. 2005; Inactivation of the viral interleukin 1 β receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara. J Gen Virol 86:1997–2006 [CrossRef]
    [Google Scholar]
  27. Symons J. A., Tscharke D. C., Price N., Smith G. L. 2002; A study of the vaccinia virus interferon- γ receptor and its contribution to virus virulence. J Gen Virol 83:1953–1964
    [Google Scholar]
  28. Thompson J. D., Higgins D. G., Gibson T. J. 1994; clustal w: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680 [CrossRef]
    [Google Scholar]
  29. Tscharke D. C., Smith G. L. 1999; A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. J Gen Virol 80:2751–2755
    [Google Scholar]
  30. Tscharke D. C., Reading P. C., Smith G. L. 2002; Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol 83:1977–1986
    [Google Scholar]
  31. Tulman E. R., Delhon G., Afonso C. L., Lu Z., Zsak L., Sandybaev N. T., Kerembekova U. Z., Zaitsev V. L., Kutish G. F., Rock D. L. 2006; Genome of horsepox virus. J Virol 80:9244–9258 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82748-0
Loading
/content/journal/jgv/10.1099/vir.0.82748-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error